Deccan Health Care Ltd.

View in App
28.44 -0.84 ▼-2.9%

30 November 2023, 01:47:00 PM
Volume: 64,412

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.deccanhealthcare.co.in / www.beyoungstore.com
Market Cap 57.09 Cr.
Enterprise Value(EV) 59.33 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 0.18 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 156.85 Trailing Twelve Months Ending 2023-03
Industry PE 38.14 Trailing Twelve Months Ending 2023-03
Book Value / Share 45.35 Trailing Twelve Months Ending 2023-03
Price to Book Value 0.62 Calculated using Price: 28.02
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 2.04 Cr. 20,376,180 Shares
FaceValue 10
About Deccan Health Care Ltd.
The Company is engaged in developing, manufacturing and marketing a broad range of healthcare products including nutraceutical, cosmeceutical and ayurveda products. The Company offers more than 1500 products. These products are used for various purposes such as hair care, skin care, heart care, immunity building etc. The Company offers a long-chain omerga-3 fatty acid, joint health nutrients, diacerein, antioxidants, immune enhancing components, skin ageing products, instant energy drinks, and calcium supplements; and a formula for males. The Company supplies their products in various forms such as tablets, capsules, gel, liquids, ointments, powder, pastes, etc.

Deccan Health Care Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Deccan Health Care Ltd. Performance

View details >>
1 Day
-2.87%
1 Week
-3.10%
1 Month
-8.55%
3 Month
-7.75%
6 Month
-12.49%
1 Year
-28.36%
2 Year
+3.23%
5 Year
10 Year

Deccan Health Care Ltd. Fundamental Ratios

View details >>
3 years 2021-03 2022-03 2023-03
Return on Equity (%) 0.51 0.42 0.46
Return on Capital Employed (%) 0.81 0.89 0.78
Return on Assets (%) 0.42 0.35 0.39

Deccan Health Care Ltd. Balance Sheet

View details >>
Particulars 4 years 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 77 77 82 82
Non Curr. Liab. 3 3 3 3
Curr. Liab. 13 10 12 17
Minority Int.
Equity & Liab. 92 91 97 102
Non Curr. Assets 26 23 21 20
Curr. Assets 66 68 76 82
Misc. Exp. not W/O
Total Assets 92 91 97 102

Deccan Health Care Ltd. Profit and Loss

View details >>
Particulars 3 years 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Net Sales 34 33 45
Other Income 0 0 0
Total Income 34 33 45
Total Expenditure -32 -28 -43
PBIDT 2 6 2
Interest 0 0 0
Depreciation -1 -1 -1
Taxation 0 0 0
Exceptional Items -3
PAT 0 0 0
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 0 0 0
Adjusted EPS 0 0 0

Deccan Health Care Ltd. Cash Flow

View details >>
Particulars 3 years 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 -1 -7
Cash Fr. Inv. 0 0 0
Cash Fr. Finan. 0 0 5
Net Change 0 -1 -1
Cash & Cash Eqvt 3 3 1

Deccan Health Care Ltd. Shareholding Pattern

View details >>
9 Qtrs 2020-03 (%) 2020-09 (%) 2021-03 (%) 2021-09 (%) 2022-03 (%) 2022-09 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 45.61 35.94 35.70 34.89 27.60 22.21 22.21 19.27 19.27
Public 54.39 64.06 64.30 65.11 72.40 77.79 77.79 80.73 80.73
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.07 0.08 0.10 0.00 0.00 0.00

Deccan Health Care Ltd. Announcements

View details >>
Sun, 12 Nov 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find attached newspaper publication of Financial Results for the quarter ended September 30 2023.
Sat, 11 Nov 2023
Financial Results For The Quarter Ended September 30 2023
Financial Results for the quarter ended September 30 2023
Sat, 11 Nov 2023
Board Meeting Outcome for Outcome Of The Board Meeting Held On Today I.E. November 11 2023 And Submission Of Unaudited Financial Results (Standalone & Consolidated) For The Quarter Ended September 30 2023
With reference to our Intimation vide letter dated Friday November 03 2023 we wish to inform you that the Board Directors of the Company in its meeting held today i.e. Saturday November 11 2023 through Video Conferencing/OAVM have Inter-alia;1. Considered and Approved the Standalone Unaudited Financial Results of the Company for the quarter ended September 30 2023 along with the Limited Review Report.2. Considered and Approved the Consolidated Unaudited Financial Results of the Company for the quarter ended on September 30 2023 along with the Limited Review Report.The Board Meeting commenced at 11:30 AM and concluded at 11:50 AM

Deccan Health Care Ltd. Technical Scans

View details >>
Wed, 29 Nov 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Opening at Low Opening at Low
High Decrease in 1 Month High Decrease in 1 Month

Deccan Health Care Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 288,124.14 1,217.45 +1.3%
Divi's Laboratories Ltd. 98,985.27 3,798.40 +1.8%
Cipla Ltd. 97,035.44 1,203.00 +0.1%
Dr. Reddy's Laboratories Ltd. 95,335.50 5,751.25 +0.6%
Apollo Hospitals Enterprise Ltd. 77,919.78 5,506.05 +1.6%
Mankind Pharma Ltd. 76,041.70 1,898.45 0.0%
Torrent Pharmaceuticals Ltd. 70,779.09 2,121.85 +1.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 33.70 1,217.45 +1.3%
Divi's Laboratories Ltd. Consolidated 2023-09 74.33 3,798.40 +1.8%
Cipla Ltd. Consolidated 2023-09 28.10 1,203.00 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.73 5,751.25 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 111.72 5,506.05 +1.6%
Mankind Pharma Ltd. Consolidated 2023-03 59.32 1,898.45 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 53.06 2,121.85 +1.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.82 1,217.45 +1.3%
Divi's Laboratories Ltd. Consolidated 2023-09 7.81 3,798.40 +1.8%
Cipla Ltd. Consolidated 2023-09 3.91 1,203.00 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.74 5,751.25 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 11.99 5,506.05 +1.6%
Mankind Pharma Ltd. Consolidated 2023-03 9.02 1,898.45 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.55 2,121.85 +1.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,217.45 +1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,798.40 +1.8%
Cipla Ltd. Consolidated 2023-03 0.02 1,203.00 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,751.25 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,506.05 +1.6%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,898.45 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,121.85 +1.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,217.45 +1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,798.40 +1.8%
Cipla Ltd. Consolidated 2023-03 12.85 1,203.00 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,751.25 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,506.05 +1.6%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,898.45 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,121.85 +1.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,217.45 +1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,798.40 +1.8%
Cipla Ltd. Consolidated 2023-03 12.85 1,203.00 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,751.25 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,506.05 +1.6%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,898.45 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,121.85 +1.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,217.45 +1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,798.40 +1.8%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,203.00 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,751.25 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,506.05 +1.6%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,898.45 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,121.85 +1.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,217.45 +1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,798.40 +1.8%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,203.00 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,751.25 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,506.05 +1.6%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,898.45 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,121.85 +1.4%

Deccan Health Care Ltd. FAQ's

What is Deccan Health Care share price?
Can I buy Deccan Health Care shares now?
What is the Market Cap of Deccan Health Care?
What are the key metrics to analyse Deccan Health Care?
What is the 52 Week High and Low of Deccan Health Care?
What is the trend of Deccan Health Care share price?